BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38265288)

  • 1. The impact of glucagon to support postabsorptive glucose flux and glycemia in healthy rats and its attenuation in male Zucker diabetic fatty rats.
    Estes SK; Shiota C; O'Brien TP; Printz RL; Shiota M
    Am J Physiol Endocrinol Metab; 2024 Mar; 326(3):E308-E325. PubMed ID: 38265288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective glycogenesis contributes toward the inability to suppress hepatic glucose production in response to hyperglycemia and hyperinsulinemia in zucker diabetic fatty rats.
    Torres TP; Fujimoto Y; Donahue EP; Printz RL; Houseknecht KL; Treadway JL; Shiota M
    Diabetes; 2011 Sep; 60(9):2225-33. PubMed ID: 21771972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gluconeogenesis in moderately and severely hyperglycemic patients with type 2 diabetes mellitus.
    Boden G; Chen X; Stein TP
    Am J Physiol Endocrinol Metab; 2001 Jan; 280(1):E23-30. PubMed ID: 11120655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose toxicity is responsible for the development of impaired regulation of endogenous glucose production and hepatic glucokinase in Zucker diabetic fatty rats.
    Fujimoto Y; Torres TP; Donahue EP; Shiota M
    Diabetes; 2006 Sep; 55(9):2479-90. PubMed ID: 16936196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restoration of hepatic glucokinase expression corrects hepatic glucose flux and normalizes plasma glucose in zucker diabetic fatty rats.
    Torres TP; Catlin RL; Chan R; Fujimoto Y; Sasaki N; Printz RL; Newgard CB; Shiota M
    Diabetes; 2009 Jan; 58(1):78-86. PubMed ID: 18952838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correcting Postprandial Hyperglycemia in Zucker Diabetic Fatty Rats With an SGLT2 Inhibitor Restores Glucose Effectiveness in the Liver and Reduces Insulin Resistance in Skeletal Muscle.
    O'Brien TP; Jenkins EC; Estes SK; Castaneda AV; Ueta K; Farmer TD; Puglisi AE; Swift LL; Printz RL; Shiota M
    Diabetes; 2017 May; 66(5):1172-1184. PubMed ID: 28246292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of endogenous glucose production by glucose per se is impaired in type 2 diabetes mellitus.
    Mevorach M; Giacca A; Aharon Y; Hawkins M; Shamoon H; Rossetti L
    J Clin Invest; 1998 Aug; 102(4):744-53. PubMed ID: 9710443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of glucagon on carbohydrate metabolism in Zucker fatty rats.
    Nishikawa K; Ikeda H; Matsuo T
    Horm Metab Res; 1981 Aug; 13(8):426-30. PubMed ID: 7035320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucotoxicity targets hepatic glucokinase in Zucker diabetic fatty rats, a model of type 2 diabetes associated with obesity.
    Ueta K; O'Brien TP; McCoy GA; Kim K; Healey EC; Farmer TD; Donahue EP; Condren AB; Printz RL; Shiota M
    Am J Physiol Endocrinol Metab; 2014 Jun; 306(11):E1225-38. PubMed ID: 24714398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the role of the gut in diabetic hyperglucagonaemia.
    Lund A
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A defect in glucose-induced dissociation of glucokinase from the regulatory protein in Zucker diabetic fatty rats in the early stage of diabetes.
    Shin JS; Torres TP; Catlin RL; Donahue EP; Shiota M
    Am J Physiol Regul Integr Comp Physiol; 2007 Apr; 292(4):R1381-90. PubMed ID: 17204595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type 2 diabetic patients have increased gluconeogenic efficiency to substrate availability, but intact autoregulation of endogenous glucose production.
    Toft I; Jenssen T
    Scand J Clin Lab Invest; 2005; 65(4):307-20. PubMed ID: 16076686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in plasma homocysteine levels between Zucker fatty and Zucker diabetic fatty rats following 3 weeks oral administration of organic vanadium compounds.
    Wasan KM; Risovic V; Yuen VG; McNeill JH
    J Trace Elem Med Biol; 2006; 19(4):251-8. PubMed ID: 16443173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postprandial Aminogenic Insulin and Glucagon Secretion Can Stimulate Glucose Flux in Humans.
    Ang T; Bruce CR; Kowalski GM
    Diabetes; 2019 May; 68(5):939-946. PubMed ID: 30833465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defect in glucokinase translocation in Zucker diabetic fatty rats.
    Fujimoto Y; Donahue EP; Shiota M
    Am J Physiol Endocrinol Metab; 2004 Sep; 287(3):E414-23. PubMed ID: 15138155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mild Physiologic Hyperglycemia Induces Hepatic Insulin Resistance in Healthy Normal Glucose-Tolerant Participants.
    Tripathy D; Merovci A; Basu R; Abdul-Ghani M; DeFronzo RA
    J Clin Endocrinol Metab; 2019 Jul; 104(7):2842-2850. PubMed ID: 30789980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperglucagonemia precedes a decline in insulin secretion and causes hyperglycemia in chronically glucose-infused rats.
    Jamison RA; Stark R; Dong J; Yonemitsu S; Zhang D; Shulman GI; Kibbey RG
    Am J Physiol Endocrinol Metab; 2011 Dec; 301(6):E1174-83. PubMed ID: 21862723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperglucagonemia Mitigates the Effect of Metformin on Glucose Production in Prediabetes.
    Konopka AR; Esponda RR; Robinson MM; Johnson ML; Carter RE; Schiavon M; Cobelli C; Wondisford FE; Lanza IR; Nair KS
    Cell Rep; 2016 May; 15(7):1394-1400. PubMed ID: 27160898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent intermittent restraint delays fed and fasting hyperglycemia and improves glucose return to baseline levels during glucose tolerance tests in the Zucker diabetic fatty rat--role of food intake and corticosterone.
    Bates HE; Kiraly MA; Yue JT; Goche Montes D; Elliott ME; Riddell MC; Matthews SG; Vranic M
    Metabolism; 2007 Aug; 56(8):1065-75. PubMed ID: 17618951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormone-independent activation of EGP during hypoglycemia is absent in type 1 diabetes mellitus.
    Mevorach M; Kaplan J; Chang CJ; Rossetti L; Shamoon H
    Am J Physiol Endocrinol Metab; 2000 Mar; 278(3):E421-9. PubMed ID: 10710496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.